- Home
- BFAM vs LEGN Comparison
BFAM vs LEGN Comparison
Compare BFAM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFAM
- LEGN
- Stock Information
- Founded
- BFAM 1986
- LEGN 2014
- Country
- BFAM United States
- LEGN United States
- Employees
- BFAM N/A
- LEGN N/A
- Industry
- BFAM Other Consumer Services
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- BFAM Consumer Discretionary
- LEGN Health Care
- Exchange
- BFAM Nasdaq
- LEGN Nasdaq
- Market Cap
- BFAM 6.9B
- LEGN 7.0B
- IPO Year
- BFAM 1997
- LEGN 2020
- Fundamental
- Price
- BFAM $123.38
- LEGN $38.05
- Analyst Decision
- BFAM Buy
- LEGN Strong Buy
- Analyst Count
- BFAM 8
- LEGN 13
- Target Price
- BFAM $138.38
- LEGN $79.67
- AVG Volume (30 Days)
- BFAM 478.1K
- LEGN 1.2M
- Earning Date
- BFAM 05-01-2025
- LEGN 03-11-2025
- Dividend Yield
- BFAM N/A
- LEGN N/A
- EPS Growth
- BFAM 87.50
- LEGN N/A
- EPS
- BFAM 2.40
- LEGN N/A
- Revenue
- BFAM $2,686,013,000.00
- LEGN $627,241,000.00
- Revenue This Year
- BFAM $9.20
- LEGN $66.60
- Revenue Next Year
- BFAM $7.81
- LEGN $49.28
- P/E Ratio
- BFAM $52.09
- LEGN N/A
- Revenue Growth
- BFAM 11.07
- LEGN 119.97
- 52 Week Low
- BFAM $100.59
- LEGN $30.17
- 52 Week High
- BFAM $141.90
- LEGN $69.17
- Technical
- Relative Strength Index (RSI)
- BFAM 47.21
- LEGN 57.06
- Support Level
- BFAM $122.18
- LEGN $33.81
- Resistance Level
- BFAM $130.50
- LEGN $35.77
- Average True Range (ATR)
- BFAM 2.93
- LEGN 1.95
- MACD
- BFAM -0.93
- LEGN 0.22
- Stochastic Oscillator
- BFAM 15.44
- LEGN 76.84
About BFAM Bright Horizons Family Solutions Inc.
Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.